Biocomposites

Biocomposites is a renowned international medical device company that specializes in engineering, manufacturing, and marketing leading products for infection management in bone and soft tissue. Based in Keele, UK, the company has established global operations across Europe, USA, Canada, China, and India. Since its establishment in 1997, Biocomposites has been a pioneer in developing innovative calcium compounds for surgical use, addressing a wide range of infection risks across various specialties including musculoskeletal infection, orthopedics, trauma, spine, foot, and ankle, as well as podiatry. With products utilized in over 100,000 procedures annually and distributed in more than 40 countries worldwide, Biocomposites has garnered significant traction in the industry. Notably, the company secured a Private Equity Round investment on 08 June 2017, with TA Associates serving as the investors. For further insights, visit biocomposites.com.